| MP term | FDR (all) | IC level | SDMP level | Annotation (direct or inherited) |
Mammalian Phenotype (MP) | abnormal definitive hematopoiesis | 0.000000001434 | 1.126 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal T cell morphology | 0.000000001737 | 1.36 | -- | DIRECT |
Mammalian Phenotype (MP) | digestive/alimentary phenotype | 0.00000001273 | 0.9267 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal apoptosis | 0.00000004876 | 1.059 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal lymphocyte morphology | 0.0000009551 | 1.059 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal leukopoiesis | 0.0000009973 | 1.228 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal intercellular signaling peptide or protein level | 0.000001341 | 1.427 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal blood cell physiology | 0.000002204 | 0.9267 | -- | DIRECT |
Mammalian Phenotype (MP) | skeleton phenotype | 0.000002773 | 0.8437 | -- | DIRECT |
Mammalian Phenotype (MP) | increased chronic myelocytic leukemia incidence | 0.000002919 | 2.205 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal spinal cord dorsal column morphology | 0.000002919 | 2.205 | -- | DIRECT |
Mammalian Phenotype (MP) | craniofacial phenotype | 0.000009892 | 1.205 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal circulating interferon-gamma level | 0.00001038 | 1.728 | -- | DIRECT |
Mammalian Phenotype (MP) | absent sternum | 0.00001139 | 2.507 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal cell physiology | 0.00001323 | 0.6144 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal cranium morphology | 0.00001376 | 1.302 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal myeloid leukocyte morphology | 0.0000261 | 1.465 | -- | DIRECT |
Mammalian Phenotype (MP) | endocrine/exocrine gland phenotype | 0.00003905 | 0.8075 | -- | DIRECT |
Mammalian Phenotype (MP) | small Peyer's patches | 0.00004658 | 2.205 | -- | DIRECT |
Mammalian Phenotype (MP) | limbs/digits/tail phenotype | 0.00005789 | 1.251 | -- | DIRECT |
Mammalian Phenotype (MP) | no abnormal phenotype detected | 0.00006655 | 1.661 | -- | DIRECT |
Mammalian Phenotype (MP) | embryonic lethality during organogenesis, complete penetrance | 0.00007162 | 2.507 | -- | DIRECT |
Mammalian Phenotype (MP) | muscle phenotype | 0.0001107 | 0.8163 | -- | DIRECT |
Mammalian Phenotype (MP) | acanthosis | 0.0001412 | 2.205 | -- | DIRECT |
Mammalian Phenotype (MP) | epidermis stratum spinosum hyperplasia | 0.0001707 | 2.205 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal dendritic cell number | 0.0002034 | 2.205 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal leukocyte morphology | 0.000238 | 0.9383 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal hemopoiesis | 0.0002482 | 1.109 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal inguinal lymph node morphology | 0.000275 | 2.205 | -- | DIRECT |
Mammalian Phenotype (MP) | decreased Peyer's patch number | 0.0003156 | 2.507 | -- | DIRECT |
Mammalian Phenotype (MP) | impaired natural killer cell mediated cytotoxicity | 0.000358 | 1.728 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal hematopoietic system physiology | 0.0003757 | 0.9154 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal zygomatic arch morphology | 0.0003775 | 2.507 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal lymphopoiesis | 0.0004338 | 1.228 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal dendritic cell morphology | 0.0006624 | 2.205 | -- | DIRECT |
Mammalian Phenotype (MP) | decreased erythroid progenitor cell number | 0.0007476 | 2.507 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal insulin-like growth factor I level | 0.0007553 | 1.808 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal vascular development | 0.0007656 | 1.393 | -- | DIRECT |
Mammalian Phenotype (MP) | increased IgG2a level | 0.0007939 | 2.507 | -- | DIRECT |
Mammalian Phenotype (MP) | homeostasis/metabolism phenotype | 0.0007947 | 0.3604 | -- | DIRECT |
Mammalian Phenotype (MP) | embryonic lethality, incomplete penetrance | 0.0008834 | 2.507 | -- | DIRECT |
Mammalian Phenotype (MP) | head tilt | 0.0009484 | 2.205 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal stomach mucosa morphology | 0.001218 | 2.205 | -- | INHERITED FROM: abnormal stomach epithelium morphology |
Mammalian Phenotype (MP) | abnormal cardiovascular development | 0.001232 | 1.302 | -- | INHERITED FROM: abnormal heart development || abnormal vascular development |
Mammalian Phenotype (MP) | increased hematopoietic cell number | 0.001547 | 1.427 | -- | INHERITED FROM: increased leukocyte cell number |
Mammalian Phenotype (MP) | abnormal skin adnexa morphology | 0.001574 | 1.184 | -- | INHERITED FROM: abnormal coat appearance || abnormal mammary gland alveolus morphology |
Mammalian Phenotype (MP) | abnormal granulocyte morphology | 0.001647 | 1.904 | -- | INHERITED FROM: abnormal granulocyte number |
Mammalian Phenotype (MP) | abnormal response to infection | 0.00172 | 1.251 | -- | INHERITED FROM: increased susceptibility to infection |
Mammalian Phenotype (MP) | abnormal immune system physiology | 0.002571 | 0.7357 | -- | INHERITED FROM: abnormal level of surface class II molecules || impaired natural killer cell mediated cytotoxicity || increased IgG2a level || abnormal B cell proliferation || abnormal leukocyte physiology || increased susceptibility to infection || abnormal interleukin level || decreased B cell proliferation || respiratory system inflammation || abnormal circulating interferon-gamma level |
Mammalian Phenotype (MP) | abnormal immune cell physiology | 0.003088 | 0.9624 | -- | INHERITED FROM: increased IgG2a level || impaired natural killer cell mediated cytotoxicity || abnormal leukocyte physiology || abnormal level of surface class II molecules || abnormal B cell proliferation || decreased B cell proliferation |
Mammalian Phenotype (MP) | abnormal cell-mediated immunity | 0.003492 | 0.9624 | -- | INHERITED FROM: impaired natural killer cell mediated cytotoxicity || abnormal leukocyte physiology || increased IgG2a level || decreased B cell proliferation || abnormal B cell proliferation || abnormal level of surface class II molecules |
Mammalian Phenotype (MP) | abnormal immune system morphology | 0.003665 | 0.7989 | -- | INHERITED FROM: decreased Peyer's patch number || abnormal thymus morphology || abnormal dendritic cell number || abnormal T cell differentiation || abnormal dendritic cell morphology || decreased dendritic cell number || abnormal granulocyte number || abnormal thymus medulla morphology || abnormal leukocyte morphology || small Peyer's patches || abnormal leukopoiesis || abnormal mononuclear cell morphology || abnormal inguinal lymph node morphology || abnormal lymphocyte morphology || abnormal T cell morphology || increased leukocyte cell number || abnormal myeloid leukocyte morphology || abnormal lymphopoiesis |
Mammalian Phenotype (MP) | abnormal palate development | 0.003789 | 2.029 | -- | INHERITED FROM: abnormal secondary palate development |
Mammalian Phenotype (MP) | abnormal hepatobiliary system physiology | 0.003994 | 1.302 | -- | INHERITED FROM: abnormal liver physiology |
Mammalian Phenotype (MP) | abnormal adaptive immunity | 0.004504 | 0.9502 | -- | INHERITED FROM: abnormal leukocyte physiology || impaired natural killer cell mediated cytotoxicity || increased IgG2a level || abnormal B cell proliferation || decreased B cell proliferation || abnormal level of surface class II molecules |
Mammalian Phenotype (MP) | behavior/neurological phenotype | 0.004572 | 0.9267 | -- | INHERITED FROM: head tilt |
Mammalian Phenotype (MP) | abnormal apocrine gland morphology | 0.0049 | 1.465 | -- | INHERITED FROM: abnormal mammary gland alveolus morphology |
Mammalian Phenotype (MP) | abnormal gut-associated lymphoid tissue morphology | 0.005861 | 1.728 | -- | INHERITED FROM: small Peyer's patches || decreased Peyer's patch number |
Mammalian Phenotype (MP) | increased malignant tumor incidence | 0.007122 | 1.661 | -- | INHERITED FROM: increased adenocarcinoma incidence |
Mammalian Phenotype (MP) | abnormal endocrine gland morphology | 0.008059 | 1.33 | -- | INHERITED FROM: abnormal thymus medulla morphology || abnormal thymus morphology |
Mammalian Phenotype (MP) | abnormal lymphocyte physiology | 0.01037 | 1.184 | -- | INHERITED FROM: increased IgG2a level || impaired natural killer cell mediated cytotoxicity || abnormal level of surface class II molecules || abnormal B cell proliferation || decreased B cell proliferation |
Mammalian Phenotype (MP) | abnormal antigen presentation | 0.01395 | 1.661 | -- | INHERITED FROM: abnormal level of surface class II molecules |
Mammalian Phenotype (MP) | abnormal respiratory system physiology | 0.01528 | 1.33 | -- | INHERITED FROM: respiratory system inflammation |
Mammalian Phenotype (MP) | abnormal erythroid progenitor cell morphology | 0.02309 | 2.507 | -- | INHERITED FROM: decreased erythroid progenitor cell number |
Mammalian Phenotype (MP) | decreased hematopoietic cell number | 0.02783 | 1.184 | -- | INHERITED FROM: decreased dendritic cell number |
Mammalian Phenotype (MP) | abnormal NK cell physiology | 0.0302 | 1.661 | -- | INHERITED FROM: impaired natural killer cell mediated cytotoxicity |
Mammalian Phenotype (MP) | abnormal cytokine level | 0.0337 | 1.465 | -- | INHERITED FROM: abnormal interleukin level || abnormal circulating interferon-gamma level |
Mammalian Phenotype (MP) | abnormal leukocyte cell number | 0.03972 | 1.044 | -- | INHERITED FROM: decreased dendritic cell number || increased leukocyte cell number || abnormal granulocyte number || abnormal dendritic cell number |
Mammalian Phenotype (MP) | lethality throughout fetal growth and development | 0.04699 | 1.808 | -- | INHERITED FROM: lethality throughout fetal growth and development, complete penetrance |
Mammalian Phenotype (MP) | increased tumor incidence | 0.04784 | 1.109 | -- | INHERITED FROM: increased chronic myelocytic leukemia incidence || increased adenocarcinoma incidence |
Mammalian Phenotype (MP) | abnormal circulating interferon level | 0.05019 | 1.661 | -- | INHERITED FROM: abnormal circulating interferon-gamma level |
Mammalian Phenotype (MP) | abnormal immunoglobulin level | 0.05514 | 1.661 | -- | INHERITED FROM: increased IgG2a level |
Mammalian Phenotype (MP) | abnormal motor capabilities/coordination/movement | 0.06282 | 1.228 | -- | INHERITED FROM: head tilt |
Mammalian Phenotype (MP) | abnormal antigen presentation via MHC class II | 0.06402 | 1.808 | -- | INHERITED FROM: abnormal level of surface class II molecules |
Mammalian Phenotype (MP) | abnormal professional antigen presenting cell morphology | 0.06591 | 1.276 | -- | INHERITED FROM: abnormal dendritic cell number || decreased dendritic cell number || abnormal dendritic cell morphology |
Mammalian Phenotype (MP) | abnormal craniofacial bone morphology | 0.06609 | 1.302 | -- | INHERITED FROM: abnormal cranium morphology || abnormal zygomatic arch morphology |
Mammalian Phenotype (MP) | abnormal innate immunity | 0.08777 | 1.276 | -- | INHERITED FROM: impaired natural killer cell mediated cytotoxicity |
Mammalian Phenotype (MP) | abnormal cervical vertebrae morphology | 0.09101 | 2.029 | -- | INHERITED FROM: abnormal cervical atlas morphology |
Mammalian Phenotype (MP) | abnormal circulating protein level | 0.09743 | 1.251 | -- | INHERITED FROM: abnormal circulating interferon-gamma level |
Mammalian Phenotype (MP) | abnormal B cell physiology | 0.09867 | 1.228 | -- | INHERITED FROM: abnormal level of surface class II molecules || increased IgG2a level || abnormal B cell proliferation || decreased B cell proliferation |
Mammalian Phenotype (MP) | increased immunoglobulin level | 0.1046 | 2.205 | -- | INHERITED FROM: increased IgG2a level |
Mammalian Phenotype (MP) | abnormal stomach wall morphology | 0.106 | 2.205 | -- | INHERITED FROM: abnormal stomach epithelium morphology |
Mammalian Phenotype (MP) | abnormal Peyer's patch number | 0.1104 | 2.507 | -- | INHERITED FROM: decreased Peyer's patch number |
Mammalian Phenotype (MP) | abnormal hematopoietic system morphology/development | 0.1185 | 0.7357 | -- | INHERITED FROM: abnormal mononuclear cell morphology || abnormal definitive hematopoiesis || abnormal leukopoiesis || abnormal hemopoiesis || abnormal thymus medulla morphology || abnormal leukocyte morphology || abnormal granulocyte number || abnormal blood cell morphology || abnormal lymphopoiesis || abnormal myeloid leukocyte morphology || increased leukocyte cell number || abnormal T cell morphology || abnormal lymphocyte morphology || abnormal dendritic cell number || abnormal thymus morphology || abnormal blood cell morphology/development || decreased dendritic cell number || decreased erythroid progenitor cell number || abnormal dendritic cell morphology || abnormal T cell differentiation |
Mammalian Phenotype (MP) | abnormal presacral vertebrae morphology | 0.1188 | 1.661 | -- | INHERITED FROM: abnormal cervical atlas morphology |
Mammalian Phenotype (MP) | abnormal skin adnexa physiology | 0.1451 | 1.808 | -- | INHERITED FROM: abnormal mammary gland epithelium physiology |
Mammalian Phenotype (MP) | abnormal mammary gland physiology | 0.1542 | 1.904 | -- | INHERITED FROM: abnormal mammary gland epithelium physiology |
Mammalian Phenotype (MP) | abnormal exocrine gland morphology | 0.155 | 1.251 | -- | INHERITED FROM: abnormal mammary gland alveolus morphology |
Mammalian Phenotype (MP) | abnormal B cell activation | 0.1587 | 1.661 | -- | INHERITED FROM: abnormal B cell proliferation || decreased B cell proliferation |
Mammalian Phenotype (MP) | abnormal mammary gland lobule morphology | 0.1614 | 1.904 | -- | INHERITED FROM: abnormal mammary gland alveolus morphology |
Mammalian Phenotype (MP) | increased IgG2 level | 0.1768 | 2.507 | -- | INHERITED FROM: increased IgG2a level |
Mammalian Phenotype (MP) | abnormal classified tumor incidence | 0.1855 | 1.205 | -- | INHERITED FROM: increased adenocarcinoma incidence || increased chronic myelocytic leukemia incidence |
Mammalian Phenotype (MP) | abnormal mouth morphology | 0.2422 | 1.728 | -- | INHERITED FROM: cleft palate || abnormal secondary palate development |
Mammalian Phenotype (MP) | abnormal apocrine gland physiology | 0.2486 | 1.904 | -- | INHERITED FROM: abnormal mammary gland epithelium physiology |
Mammalian Phenotype (MP) | abnormal exocrine gland physiology | 0.2645 | 1.904 | -- | INHERITED FROM: abnormal mammary gland epithelium physiology |
Mammalian Phenotype (MP) | abnormal organ/body region tumor incidence | 0.2723 | 1.184 | -- | INHERITED FROM: increased chronic myelocytic leukemia incidence |
Mammalian Phenotype (MP) | abnormal facial morphology | 0.2777 | 1.603 | -- | INHERITED FROM: cleft palate || abnormal secondary palate development |
Mammalian Phenotype (MP) | abnormal palate morphology | 0.278 | 1.904 | -- | INHERITED FROM: abnormal secondary palate development || cleft palate |
Mammalian Phenotype (MP) | abnormal circulating hormone level | 0.2801 | 1.126 | -- | INHERITED FROM: abnormal circulating insulin-like growth factor I level |
Mammalian Phenotype (MP) | abnormal axial skeleton morphology | 0.295 | 1.126 | -- | INHERITED FROM: abnormal cranium morphology || abnormal vertebral arch morphology || abnormal intervertebral disk morphology || abnormal zygomatic arch morphology || absent sternum || abnormal cervical atlas morphology |
Mammalian Phenotype (MP) | increased inflammatory response | 0.2993 | 1.145 | -- | INHERITED FROM: respiratory system inflammation |
Mammalian Phenotype (MP) | abnormal skin morphology | 0.2993 | 1.228 | -- | INHERITED FROM: epidermis stratum spinosum hyperplasia || acanthosis |
Mammalian Phenotype (MP) | abnormal immune system cell morphology | 0.3146 | 0.9267 | -- | INHERITED FROM: abnormal lymphopoiesis || decreased dendritic cell number || abnormal myeloid leukocyte morphology || increased leukocyte cell number || abnormal dendritic cell morphology || abnormal T cell morphology || abnormal T cell differentiation || abnormal lymphocyte morphology || abnormal mononuclear cell morphology || abnormal leukopoiesis || abnormal dendritic cell number || abnormal leukocyte morphology || abnormal granulocyte number |
Mammalian Phenotype (MP) | increased classified tumor incidence | 0.3204 | 1.205 | -- | INHERITED FROM: increased chronic myelocytic leukemia incidence || increased adenocarcinoma incidence |
Mammalian Phenotype (MP) | preweaning lethality | 0.3211 | 0.8253 | -- | INHERITED FROM: embryonic lethality during organogenesis, complete penetrance || embryonic lethality, incomplete penetrance || lethality throughout fetal growth and development, complete penetrance |
Mammalian Phenotype (MP) | abnormal blood circulation | 0.3283 | 1.276 | -- | INHERITED FROM: hemorrhage |
Mammalian Phenotype (MP) | abnormal nervous system morphology | 0.3404 | 0.6257 | -- | INHERITED FROM: abnormal spinal cord dorsal column morphology |
Mammalian Phenotype (MP) | abnormal stationary movement | 0.3552 | 2.029 | -- | INHERITED FROM: head tilt |
Mammalian Phenotype (MP) | abnormal IgG level | 0.3685 | 1.808 | -- | INHERITED FROM: increased IgG2a level |
Mammalian Phenotype (MP) | abnormal thymus lobule morphology | 0.4122 | 1.904 | -- | INHERITED FROM: abnormal thymus medulla morphology |
Mammalian Phenotype (MP) | increased organ/body region tumor incidence | 0.4287 | 1.184 | -- | INHERITED FROM: increased chronic myelocytic leukemia incidence |
Mammalian Phenotype (MP) | abnormal craniofacial development | 0.4394 | 2.029 | -- | INHERITED FROM: abnormal secondary palate development |
Mammalian Phenotype (MP) | abnormal survival | 0.464 | 0.7284 | -- | INHERITED FROM: embryonic lethality during organogenesis, complete penetrance || lethality throughout fetal growth and development, complete penetrance || embryonic lethality, incomplete penetrance |
Mammalian Phenotype (MP) | abnormal cardiovascular system morphology | 0.5068 | 0.8253 | -- | INHERITED FROM: abnormal vascular development || abnormal heart development |
Mammalian Phenotype (MP) | altered susceptibility to infection | 0.5429 | 1.251 | -- | INHERITED FROM: increased susceptibility to infection |
Mammalian Phenotype (MP) | altered tumor susceptibility | 0.5517 | 1.109 | -- | INHERITED FROM: increased chronic myelocytic leukemia incidence || increased adenocarcinoma incidence |
Mammalian Phenotype (MP) | abnormal pectoral girdle bone morphology | 0.5877 | 1.728 | -- | INHERITED FROM: absent sternum |
Mammalian Phenotype (MP) | abnormal coat/ hair morphology | 0.6383 | 1.603 | -- | INHERITED FROM: abnormal coat appearance |
Mammalian Phenotype (MP) | abnormal hematopoietic cell morphology | 0.6536 | 0.8075 | -- | INHERITED FROM: abnormal myeloid leukocyte morphology || increased leukocyte cell number || abnormal lymphopoiesis || abnormal lymphocyte morphology || abnormal T cell morphology || abnormal mononuclear cell morphology || abnormal leukopoiesis || abnormal definitive hematopoiesis || abnormal blood cell morphology || abnormal granulocyte number || abnormal leukocyte morphology || abnormal hemopoiesis || decreased dendritic cell number || decreased erythroid progenitor cell number || abnormal dendritic cell morphology || abnormal T cell differentiation || abnormal dendritic cell number |
Mammalian Phenotype (MP) | embryonic lethality | 0.7236 | 1.302 | -- | INHERITED FROM: embryonic lethality, incomplete penetrance || embryonic lethality during organogenesis, complete penetrance |
Mammalian Phenotype (MP) | abnormal vertebral column morphology | 0.7992 | 1.36 | -- | INHERITED FROM: abnormal vertebral arch morphology || abnormal intervertebral disk morphology || abnormal cervical atlas morphology |
Mammalian Phenotype (MP) | abnormal IgG2 level | 0.8114 | 1.904 | -- | INHERITED FROM: increased IgG2a level |
Mammalian Phenotype (MP) | abnormal tumor incidence | 0.9315 | 1.109 | -- | INHERITED FROM: increased adenocarcinoma incidence || increased chronic myelocytic leukemia incidence |
Mammalian Phenotype (MP) | abnormal blood homeostasis | 1 | 0.7072 | -- | INHERITED FROM: abnormal circulating insulin-like growth factor I level || abnormal circulating interferon-gamma level |
Mammalian Phenotype (MP) | growth/size/body region phenotype | 0.000001622 | 0.7003 | Least Informative | DIRECT |
Mammalian Phenotype (MP) | mortality/aging | 0.000002056 | 0.5874 | Least Informative | DIRECT |
Mammalian Phenotype (MP) | cellular phenotype | 0.0002034 | 0.5242 | Least Informative | DIRECT |
Mammalian Phenotype (MP) | cardiovascular system phenotype | 0.000342 | 0.6804 | Least Informative | DIRECT |
Mammalian Phenotype (MP) | hematopoietic system phenotype | 0.006122 | 0.6492 | Least Informative | INHERITED FROM: abnormal thymus morphology || abnormal dendritic cell number || abnormal B cell proliferation || abnormal leukocyte physiology || abnormal blood cell morphology/development || abnormal level of surface class II molecules || increased IgG2a level || decreased dendritic cell number || impaired natural killer cell mediated cytotoxicity || abnormal hematopoietic system physiology || abnormal T cell differentiation || abnormal dendritic cell morphology || decreased erythroid progenitor cell number || abnormal leukopoiesis || abnormal definitive hematopoiesis || abnormal mononuclear cell morphology || abnormal blood cell morphology || abnormal granulocyte number || abnormal leukocyte morphology || abnormal thymus medulla morphology || abnormal hemopoiesis || decreased B cell proliferation || increased leukocyte cell number || abnormal myeloid leukocyte morphology || abnormal blood cell physiology || abnormal lymphopoiesis || abnormal lymphocyte morphology || abnormal T cell morphology |
Mammalian Phenotype (MP) | immune system phenotype | 0.007579 | 0.6257 | Least Informative | INHERITED FROM: abnormal myeloid leukocyte morphology || respiratory system inflammation || abnormal T cell morphology || abnormal mononuclear cell morphology || small Peyer's patches || abnormal leukopoiesis || abnormal granulocyte number || abnormal leukocyte morphology || abnormal level of surface class II molecules || increased IgG2a level || decreased dendritic cell number || impaired natural killer cell mediated cytotoxicity || abnormal dendritic cell morphology || abnormal B cell proliferation || abnormal dendritic cell number || increased susceptibility to infection || abnormal leukocyte physiology || decreased Peyer's patch number || decreased B cell proliferation || increased leukocyte cell number || abnormal lymphopoiesis || abnormal inguinal lymph node morphology || abnormal lymphocyte morphology || abnormal circulating interferon-gamma level || abnormal thymus medulla morphology || abnormal T cell differentiation || abnormal thymus morphology || abnormal interleukin level |
Mammalian Phenotype (MP) | nervous system phenotype | 0.02698 | 0.5153 | Least Informative | INHERITED FROM: abnormal spinal cord dorsal column morphology |
Mammalian Phenotype (MP) | abnormal homeostasis | 0.1981 | 0.4937 | Least Informative | INHERITED FROM: abnormal fluid regulation || abnormal intercellular signaling peptide or protein level || abnormal insulin-like growth factor I level || abnormal circulating insulin-like growth factor I level || impaired adaptive thermogenesis || abnormal circulating interferon-gamma level || abnormal interleukin level |
Mammalian Phenotype (MP) | abnormal blood cell morphology/development | 0.000000009941 | 1.092 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal leukocyte physiology | 0.0000005025 | 0.975 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal skeleton morphology | 0.000000831 | 0.8937 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | integument phenotype | 0.000001217 | 0.8437 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | embryo phenotype | 0.000001873 | 0.9044 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | respiratory system phenotype | 0.000005447 | 0.988 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal craniofacial morphology | 0.000009462 | 1.205 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal gland morphology | 0.000009626 | 0.8833 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal mononuclear cell morphology | 0.00002869 | 0.975 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal blood cell morphology | 0.00008702 | 1.015 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | liver/biliary system phenotype | 0.0008508 | 0.9383 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal inflammatory response | 0.001447 | 1.075 | Moderately Informative | INHERITED FROM: respiratory system inflammation |
Mammalian Phenotype (MP) | abnormal immune serum protein physiology | 0.003601 | 1.126 | Moderately Informative | INHERITED FROM: increased IgG2a level || abnormal interleukin level || abnormal circulating interferon-gamma level |
Mammalian Phenotype (MP) | abnormal cell death | 0.0059 | 1.029 | Moderately Informative | INHERITED FROM: abnormal apoptosis |
Mammalian Phenotype (MP) | abnormal cardiovascular system physiology | 0.01523 | 0.9154 | Moderately Informative | INHERITED FROM: hemorrhage |
Mammalian Phenotype (MP) | abnormal immune system organ morphology | 0.02008 | 1.205 | Moderately Informative | INHERITED FROM: abnormal inguinal lymph node morphology || decreased Peyer's patch number || abnormal thymus medulla morphology || abnormal thymus morphology || small Peyer's patches |
Mammalian Phenotype (MP) | abnormal hematopoietic cell number | 0.03062 | 0.975 | Moderately Informative | INHERITED FROM: increased leukocyte cell number || decreased dendritic cell number || abnormal granulocyte number || abnormal dendritic cell number |
Mammalian Phenotype (MP) | neoplasm | 0.03177 | 1.001 | Moderately Informative | INHERITED FROM: altered tumor pathology || increased adenocarcinoma incidence || increased chronic myelocytic leukemia incidence |
Mammalian Phenotype (MP) | abnormal blood vessel morphology | 0.03402 | 1.015 | Moderately Informative | INHERITED FROM: abnormal vascular development |
Mammalian Phenotype (MP) | abnormal myeloid cell morphology | 0.04821 | 1.205 | Moderately Informative | INHERITED FROM: abnormal myeloid leukocyte morphology || abnormal granulocyte number || decreased erythroid progenitor cell number |
Mammalian Phenotype (MP) | abnormal heart morphology | 0.05445 | 1.075 | Moderately Informative | INHERITED FROM: abnormal heart development |
Mammalian Phenotype (MP) | lethality during fetal growth through weaning | 0.05842 | 1.228 | Moderately Informative | INHERITED FROM: lethality throughout fetal growth and development, complete penetrance |
Mammalian Phenotype (MP) | prenatal lethality | 0.08299 | 1.075 | Moderately Informative | INHERITED FROM: embryonic lethality during organogenesis, complete penetrance || lethality throughout fetal growth and development, complete penetrance || embryonic lethality, incomplete penetrance |
Mammalian Phenotype (MP) | abnormal digestive system morphology | 0.1005 | 1.029 | Moderately Informative | INHERITED FROM: abnormal secondary palate development || abnormal stomach epithelium morphology || cleft palate |
Mammalian Phenotype (MP) | abnormal protein level | 0.1332 | 1.145 | Moderately Informative | INHERITED FROM: abnormal circulating interferon-gamma level || abnormal interleukin level || abnormal intercellular signaling peptide or protein level |
Mammalian Phenotype (MP) | abnormal professional antigen presenting cell physiology | 0.4832 | 1.109 | Moderately Informative | INHERITED FROM: increased IgG2a level || abnormal level of surface class II molecules || decreased B cell proliferation || abnormal B cell proliferation |
Mammalian Phenotype (MP) | abnormal hormone level | 0.7241 | 1.075 | Moderately Informative | INHERITED FROM: abnormal circulating insulin-like growth factor I level || abnormal insulin-like growth factor I level |
Mammalian Phenotype (MP) | abnormal behavior | 1 | 0.9383 | Moderately Informative | INHERITED FROM: head tilt |
Mammalian Phenotype (MP) | abnormal interleukin level | 0.00000001078 | 1.603 | Informative | DIRECT |
Mammalian Phenotype (MP) | increased susceptibility to infection | 0.0000003092 | 1.465 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal liver physiology | 0.000003215 | 1.393 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal thymus morphology | 0.00001351 | 1.507 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal coat appearance | 0.00001994 | 1.603 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal T cell differentiation | 0.00003044 | 1.603 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal fluid regulation | 0.00004723 | 1.552 | Informative | DIRECT |
Mammalian Phenotype (MP) | normal phenotype | 0.00006785 | 1.603 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal B cell proliferation | 0.0001197 | 1.661 | Informative | DIRECT |
Mammalian Phenotype (MP) | hemorrhage | 0.000136 | 1.393 | Informative | DIRECT |
Mammalian Phenotype (MP) | altered tumor pathology | 0.0003108 | 1.552 | Informative | DIRECT |
Mammalian Phenotype (MP) | increased leukocyte cell number | 0.0004409 | 1.552 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal cartilage morphology | 0.002052 | 1.603 | Informative | INHERITED FROM: abnormal intervertebral disk morphology |
Mammalian Phenotype (MP) | abnormal humoral immune response | 0.003874 | 1.552 | Informative | INHERITED FROM: increased IgG2a level |
Mammalian Phenotype (MP) | abnormal adaptive thermogenesis | 0.004062 | 1.728 | Informative | INHERITED FROM: impaired adaptive thermogenesis |
Mammalian Phenotype (MP) | abnormal spinal cord morphology | 0.008851 | 1.661 | Informative | INHERITED FROM: abnormal spinal cord dorsal column morphology |
Mammalian Phenotype (MP) | abnormal epidermal layer morphology | 0.0102 | 1.552 | Informative | INHERITED FROM: epidermis stratum spinosum hyperplasia || acanthosis |
Mammalian Phenotype (MP) | abnormal circulating cytokine level | 0.01193 | 1.507 | Informative | INHERITED FROM: abnormal circulating interferon-gamma level |
Mammalian Phenotype (MP) | abnormal gland physiology | 0.0227 | 1.552 | Informative | INHERITED FROM: abnormal mammary gland epithelium physiology |
Mammalian Phenotype (MP) | abnormal B lymphocyte antigen presentation | 0.02866 | 1.661 | Informative | INHERITED FROM: abnormal level of surface class II molecules |
Mammalian Phenotype (MP) | abnormal lymph node morphology | 0.04134 | 1.552 | Informative | INHERITED FROM: abnormal inguinal lymph node morphology |
Mammalian Phenotype (MP) | abnormal head morphology | 0.04169 | 1.427 | Informative | INHERITED FROM: abnormal secondary palate development || cleft palate |
Mammalian Phenotype (MP) | abnormal interferon level | 0.07153 | 1.661 | Informative | INHERITED FROM: abnormal circulating interferon-gamma level |
Mammalian Phenotype (MP) | abnormal mammary gland morphology | 0.07608 | 1.465 | Informative | INHERITED FROM: abnormal mammary gland alveolus morphology |
Mammalian Phenotype (MP) | abnormal appendicular skeleton morphology | 0.08006 | 1.427 | Informative | INHERITED FROM: absent sternum |
Mammalian Phenotype (MP) | abnormal thoracic cage morphology | 0.2403 | 1.728 | Informative | INHERITED FROM: absent sternum |
Mammalian Phenotype (MP) | abnormal natural killer cell mediated cytotoxicity | 0.2424 | 1.661 | Informative | INHERITED FROM: impaired natural killer cell mediated cytotoxicity |
Mammalian Phenotype (MP) | abnormal stomach morphology | 0.3271 | 1.728 | Informative | INHERITED FROM: abnormal stomach epithelium morphology |
Mammalian Phenotype (MP) | increased hemolymphoid system tumor incidence | 0.3509 | 1.507 | Informative | INHERITED FROM: increased chronic myelocytic leukemia incidence |
Mammalian Phenotype (MP) | increased carcinoma incidence | 0.3809 | 1.661 | Informative | INHERITED FROM: increased adenocarcinoma incidence |
Mammalian Phenotype (MP) | abnormal voluntary movement | 0.4845 | 1.427 | Informative | INHERITED FROM: head tilt |
Mammalian Phenotype (MP) | abnormal erythroid lineage cell morphology | 0.5392 | 1.603 | Informative | INHERITED FROM: decreased erythroid progenitor cell number |
Mammalian Phenotype (MP) | abnormal vertebrae morphology | 0.6966 | 1.507 | Informative | INHERITED FROM: abnormal vertebral arch morphology || abnormal cervical atlas morphology |
Mammalian Phenotype (MP) | abnormal Peyer's patch morphology | 0.8937 | 1.728 | Informative | INHERITED FROM: decreased Peyer's patch number || small Peyer's patches |
Mammalian Phenotype (MP) | decreased B cell proliferation | 0.000006251 | 2.029 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal mammary gland epithelium physiology | 0.000009151 | 2.029 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | respiratory system inflammation | 0.000009679 | 2.205 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | lethality throughout fetal growth and development, complete penetrance | 0.00002658 | 2.029 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal secondary palate development | 0.00006098 | 2.029 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal intervertebral disk morphology | 0.0001114 | 1.904 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | impaired adaptive thermogenesis | 0.0001291 | 2.029 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | decreased dendritic cell number | 0.0001312 | 2.205 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal cervical atlas morphology | 0.0001412 | 2.029 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal stomach epithelium morphology | 0.0001707 | 2.205 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | cleft palate | 0.0002129 | 2.205 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal level of surface class II molecules | 0.000275 | 1.808 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal thymus medulla morphology | 0.0003092 | 1.904 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal heart development | 0.000321 | 1.808 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal circulating insulin-like growth factor I level | 0.0005459 | 1.808 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | increased adenocarcinoma incidence | 0.000623 | 2.029 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal granulocyte number | 0.0006581 | 2.029 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal vertebral arch morphology | 0.0008304 | 2.029 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal mammary gland alveolus morphology | 0.0008647 | 1.904 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal spinal cord white matter morphology | 0.008995 | 2.029 | Highly Informative | INHERITED FROM: abnormal spinal cord dorsal column morphology |
Mammalian Phenotype (MP) | abnormal IgG2a level | 0.01025 | 1.904 | Highly Informative | INHERITED FROM: increased IgG2a level |
Mammalian Phenotype (MP) | abnormal head movements | 0.01288 | 2.029 | Highly Informative | INHERITED FROM: head tilt |
Mammalian Phenotype (MP) | increased leukemia incidence | 0.01365 | 2.029 | Highly Informative | INHERITED FROM: increased chronic myelocytic leukemia incidence |
Mammalian Phenotype (MP) | abnormal bone marrow cell morphology/development | 0.01872 | 1.904 | Highly Informative | INHERITED FROM: decreased erythroid progenitor cell number |
Mammalian Phenotype (MP) | embryonic lethality during organogenesis | 0.06019 | 1.904 | Highly Informative | INHERITED FROM: embryonic lethality during organogenesis, complete penetrance |
Mammalian Phenotype (MP) | abnormal Peyer's patch size | 0.1245 | 1.904 | Highly Informative | INHERITED FROM: small Peyer's patches |
Mammalian Phenotype (MP) | abnormal peripheral lymph node morphology | 0.1484 | 2.029 | Highly Informative | INHERITED FROM: abnormal inguinal lymph node morphology |
Mammalian Phenotype (MP) | abnormal epidermis stratum spinosum morphology | 0.219 | 2.029 | Highly Informative | INHERITED FROM: acanthosis || epidermis stratum spinosum hyperplasia |
Mammalian Phenotype (MP) | abnormal neurocranium morphology | 0.264 | 1.808 | Highly Informative | INHERITED FROM: abnormal zygomatic arch morphology |
Mammalian Phenotype (MP) | increased IgG level | 0.3557 | 2.205 | Highly Informative | INHERITED FROM: increased IgG2a level |
Mammalian Phenotype (MP) | abnormal sternum morphology | 0.8445 | 1.904 | Highly Informative | INHERITED FROM: absent sternum |